ahpC Resolved · high auto-curated

H37Rv Rv2428 · MTBC0 mtbc0_002586 · 195 aa · 2750441–2751028 MTBC0 (+) · RefSeq NP_216944.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)alkyl hydroperoxide reductase subunit AhpC
MTBC0 PGAP re-annotationperoxiredoxin AhpC
Revised (this work)Peroxiredoxin AhpC. Pfam: AhpC-TSA (PF00578.28), Redoxin (PF08534.17).
Functional category (TubercuList)virulence, detoxification, adaptation

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 252 publications

252 TB publications mention this gene. 252 publications discuss this gene. Queried separately, 237 records carry a M. tuberculosis context and 27 a non-TB mycobacterial context (species named in the 27-record verified sample: M. smegmatis (20), M. leprae (6), M. marinum (4), M. abscessus (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 252: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Evaluation of the laboratory performance of MolecuTech®REBA MTB-MDR kit for the detection of multidrug resistant tuberculosis. doi:10.1016/j.jctube.2026.100616 2026
Association of katG, inhA, and AhpC Mutations with Isoniazid Resistance of Mycobacterium tuberculosis in Pulmonary Tuberculosis Patients from Nanjing, China. doi:10.1177/10766294261446052 2026
The performance of the WHO mutation catalog of Mycobacterium tuberculosis in the diagnosis of drug resistance to rifampicin-resistant strains in Wenzhou, China. doi:10.1128/spectrum.02481-25 2026
Mutations in oxyR and oxyR-ahpC Interogenic Region in Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Chongqing, China. doi:10.2147/IDR.S562591 2026
Prevalence and resistance spectrum of ahpC mutations in isoniazid-resistant Mycobacterium tuberculosis isolates. doi:10.1128/spectrum.02496-25 2026
251 records returned by the alias sweep (a separate sweep from the 252 above; both are shown, neither is exhaustive)

Searched as: Rv2428, ahpC, Mb2454, ML2042, MMAR_2755, MSMEG_4891, MAB_4408c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Evaluation of the laboratory performance of MolecuTech®REBA MTB-MDR kit for the detection of multidrug resistant tuberculosis. doi:10.1016/j.jctube.2026.100616 J Clin Tuberc Other Mycobact Dis 2026
Association of katG, inhA, and AhpC Mutations with Isoniazid Resistance of Mycobacterium tuberculosis in Pulmonary Tuberculosis Patients from Nanjing, China. doi:10.1177/10766294261446052 names it Microb Drug Resist 2026
The performance of the WHO mutation catalog of Mycobacterium tuberculosis in the diagnosis of drug resistance to rifampicin-resistant strains in Wenzhou, China. doi:10.1128/spectrum.02481-25 Microbiol Spectr 2026
Mutations in oxyR and oxyR-ahpC Interogenic Region in Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Chongqing, China. doi:10.2147/IDR.S562591 names it Infect Drug Resist 2026
Prevalence and resistance spectrum of ahpC mutations in isoniazid-resistant Mycobacterium tuberculosis isolates. doi:10.1128/spectrum.02496-25 names it Microbiol Spectr 2026
Predicting isoniazid resistance in Mycobacterium tuberculosis complex in New York State using whole-genome sequencing. doi:10.1128/jcm.01609-25 J Clin Microbiol 2026
Simultaneous detection of Mycobacterium tuberculosis complex and rifampin/isoniazid resistance with sanity 2.0 MTBC-MDR: a moderate-complexity automated NAAT. doi:10.1007/s11274-026-04858-5 World J Microbiol Biotechnol 2026
Comparison of long-term and short-term immunogenicity based on two different types of tuberculosis subunit vaccines. doi:10.1007/s00203-026-04733-9 Arch Microbiol 2026
iFIND INH/FQ: a LC-aNAAT assay for rapid simultaneous detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis. doi:10.1128/spectrum.03743-25 Microbiol Spectr 2026
Protein-Mediated Virulence in Mycobacterium tuberculosis. doi:10.1007/978-3-031-96883-9_5 Adv Exp Med Biol 2026
Drug resistance profile of Mycobacterium tuberculosis in China: update until 2024. doi:10.3389/fmicb.2025.1697490 Front Microbiol 2025
Inactivation of cAMP receptor protein (MSMEG_6189) increases isoniazid susceptibility in Mycobacterium smegmatis via altered oxidative phosphorylation, elevated ROS production, and loss of ahpC expression. doi:10.1128/jb.00429-25 names it J Bacteriol 2025
Discrepancies in isoniazid susceptibility profiles: Bactec MGIT 960-resistant but GenoType MTBDRplus-susceptible Mycobacterium tuberculosis strains in Hunan, China. doi:10.1128/spectrum.01101-25 Microbiol Spectr 2025
Innowave MTB/RIF/INH facilitates timely and accurate diagnosis of multiple-drug resistant tuberculosis as a near POCT technique: a multicenter prospective on-site performance evaluation study. doi:10.1186/s12941-025-00822-7 Ann Clin Microbiol Antimicrob 2025
Surveillance and analysis of drug resistance and drug resistance levels in multidrug resistant tuberculosis on the tropical islands of China. doi:10.1186/s12879-025-11312-8 BMC Infect Dis 2025
Innovo GenMax MTB-RIF/INH: a moderate-complexity automated NAAT for rapid simultaneous detection of Mycobacterium tuberculosis complex and rifampin/isoniazid resistance. doi:10.3389/fcimb.2025.1600170 Front Cell Infect Microbiol 2025
Fitness Effect of the Isoniazid Resistance Mutation S315T of the Catalase-Peroxidase Enzyme KatG of Mycobacterium tuberculosis. doi:10.1093/gbe/evaf120 Genome Biol Evol 2025
Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China. doi:10.3389/fcimb.2025.1586938 Front Cell Infect Microbiol 2025
Drug resistance profile of Mycobacterium tuberculosis complex isolated from pulmonary tuberculosis patients and their household contacts in central Ethiopia. doi:10.1186/s12879-025-11220-x BMC Infect Dis 2025
An exploratory study on the application of nanopore sequencing for detecting Mycobacterium tuberculosis drug resistance in respiratory specimens. doi:10.1186/s12890-025-03747-1 BMC Pulm Med 2025
Insights into Active Site Cysteine Residues in Mycobacterium tuberculosis Enzymes: Potential Targets for Anti-Tuberculosis Intervention. doi:10.3390/ijms26083845 Int J Mol Sci 2025
The ahpC c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis. doi:10.1128/aac.00265-25 names it Antimicrob Agents Chemother 2025
Multi-drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam. doi:10.1111/tmi.14104 Trop Med Int Health 2025
Multivariable regression models improve accuracy and sensitive grading of antibiotic resistance mutations in Mycobacterium tuberculosis. doi:10.1038/s41467-025-57174-1 Nat Commun 2025
Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China. doi:10.3389/fpubh.2025.1442987 Front Public Health 2025
Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing. doi:10.1186/s12864-024-10909-8 BMC Genomics 2024
Detection of katG, inhA and ahpC gene mutation in clinical isolates of isoniazid-resistant Mycobacterium tuberculosis in Makassar City, South Sulawesi, Indonesia. doi:10.1016/j.ijtb.2023.03.019 names it Indian J Tuberc 2024
Accurate and affordable detection of rifampicin and isoniazid resistance in Tuberculosis sputum specimens by multiplex PCR-multiple probes melting analysis. doi:10.1007/s15010-024-02295-w Infection 2024
Large-scale statistical analysis of Mycobacterium tuberculosis genome sequences identifies compensatory mutations associated with multi-drug resistance. doi:10.1038/s41598-024-62946-8 Sci Rep 2024
Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage. doi:10.1016/j.jiph.2023.07.016 J Infect Public Health 2023
In vitro modeling of isoniazid resistance mechanisms in Mycobacterium tuberculosis H37Rv. doi:10.3389/fmicb.2023.1171861 Front Microbiol 2023
Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Isolates from Southern Xinjiang, China. doi:10.2147/IDR.S407525 Infect Drug Resist 2023
Quantification of Isoniazid-Heteroresistant Mycobacterium tuberculosis Using Droplet Digital PCR. doi:10.1128/jcm.01884-22 J Clin Microbiol 2023
Drug-Resistant Tuberculosis on the Balkan Peninsula: Determination of Drug Resistance Mechanisms with Xpert MTB/XDR and Whole-Genome Sequencing Analysis. doi:10.1128/spectrum.02761-22 Microbiol Spectr 2023
Mycobacterium abscessus alkyl hydroperoxide reductase C promotes cell invasion by binding to tetraspanin CD81. doi:10.1016/j.isci.2023.106042 iScience 2023
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort. doi:10.1128/jcm.01478-22 J Clin Microbiol 2023
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis. doi:10.1038/s41598-023-27516-4 Sci Rep 2023
Genetic mutations underlying isoniazid-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan. doi:10.1016/j.tube.2022.102286 Tuberculosis (Edinb) 2023
Evaluation of Five User-Friendly Whole Genome Sequencing Software for Mycobacterium tuberculosis in Clinical Application. doi:10.3346/jkms.2022.37.e328 J Korean Med Sci 2022
Comparison on Major Gene Mutations Related to Rifampicin and Isoniazid Resistance between Beijing and Non-Beijing Strains of Mycobacterium tuberculosis: A Systematic Review and Bayesian Meta-Analysis. doi:10.3390/genes13101849 Genes (Basel) 2022
Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity. doi:10.7717/peerj.13645 PeerJ 2022
Spoligotype-based population structure and isoniazid-resistance gene mutation of Mycobacterium tuberculosis isolates from Thailand. doi:10.1016/j.jgar.2022.06.013 J Glob Antimicrob Resist 2022
Detection and characterization of mutations in genes related to isoniazid resistance in Mycobacterium tuberculosis clinical isolates from Iran. doi:10.1007/s11033-022-07404-2 Mol Biol Rep 2022
Recombinant AhpC antigen from Mycobacterium bovis boosts BCG-primed immunity in mice. doi:10.3906/biy-2108-41 names it Turk J Biol 2022
Significance of the coexistence of non-codon 315 katG, inhA, and oxyR-ahpC intergenic gene mutations among isoniazid-resistant and multidrug-resistant isolates of Mycobacterium tuberculosis: a report of novel mutations. doi:10.1080/20477724.2021.1928870 names it Pathog Glob Health 2022
Prevalence and Molecular Characteristics Based on Whole Genome Sequencing of Mycobacterium tuberculosis Resistant to Four Anti-Tuberculosis Drugs from Southern Xinjiang, China. doi:10.2147/IDR.S320024 Infect Drug Resist 2021
Phenotypic and genomic hallmarks of a novel, potentially pathogenic rapidly growing Mycobacterium species related to the Mycobacterium fortuitum complex. doi:10.1038/s41598-021-91737-8 Sci Rep 2021
Zinc limitation triggers anticipatory adaptations in Mycobacterium tuberculosis. doi:10.1371/journal.ppat.1009570 PLoS Pathog 2021
Molecular Characteristics and Drug Resistance of Mycobacterium tuberculosis Isolate Circulating in Shaanxi Province, Northwestern China. doi:10.1089/mdr.2020.0496 Microb Drug Resist 2021
Genome analyses of 174 strains of Mycobacterium tuberculosis provide insight into the evolution of drug resistance and reveal potential drug targets. doi:10.1099/mgen.0.000542 Microb Genom 2021
Comparative Study of the Susceptibility to Oxidative Stress between Two Types of Mycobacterium bovis BCG Tokyo 172. doi:10.1128/mSphere.00111-21 mSphere 2021
Genotyping and Drug Susceptibility Patterns of M. Tuberculosis Isolated from HIV Seropositive Patients in Tehran Iran. doi:10.2174/1570162X19666210226125335 Curr HIV Res 2021
Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis. doi:10.1128/AAC.02091-20 Antimicrob Agents Chemother 2021
Acetylation of Isoniazid Is a Novel Mechanism of Isoniazid Resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.00456-20 Antimicrob Agents Chemother 2020
Laboratory Evaluation of a Lateral-Flow Cell for Molecular Detection of First-Line and Second-Line Antituberculosis Drug Resistance. doi:10.1128/JCM.01417-20 J Clin Microbiol 2020
Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens. doi:10.1016/j.cmi.2020.07.004 Clin Microbiol Infect 2020
Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods. doi:10.1016/j.ijantimicag.2020.106068 Int J Antimicrob Agents 2020
Residues of helix ɑ2 are critical for catalytic efficiency of mycobacterial alkylhydroperoxide reductase subunit C. doi:10.1002/1873-3468.13864 FEBS Lett 2020
Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among Mycobacterium tuberculosis isolates from Iran. doi:10.1080/1120009X.2020.1716479 J Chemother 2020
Structure-function analyses of alkylhydroperoxidase D from Streptococcus pneumoniae reveal an unusual three-cysteine active site architecture. doi:10.1074/jbc.RA119.012226 J Biol Chem 2020
Differential Expression of Resistant and Efflux Pump Genes in MDR-TB Isolates. doi:10.2174/1871530319666191009153834 Endocr Metab Immune Disord Drug Targets 2020
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China. doi:10.1016/j.jgar.2019.08.005 J Glob Antimicrob Resist 2020
Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. doi:10.2147/IDR.S209971 Infect Drug Resist 2019
WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. doi:10.1093/jac/dkz215 J Antimicrob Chemother 2019
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine. doi:10.3390/vaccines7020040 Vaccines (Basel) 2019
Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China. doi:10.1038/s41598-019-43547-2 Sci Rep 2019
A new oligonucleotide array for the detection of multidrug and extensively drug-resistance tuberculosis. doi:10.1038/s41598-019-39339-3 Sci Rep 2019
Function of alkyl hydroperoxidase AhpD in resistance to oxidative stress in Corynebacterium glutamicum. doi:10.2323/jgam.2018.05.005 J Gen Appl Microbiol 2019
In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant Mycobacterium tuberculosis. doi:10.1080/07391102.2018.1515116 J Biomol Struct Dyn 2019
The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China. doi:10.1038/s41426-018-0184-0 names it Emerg Microbes Infect 2018
A katG S315T or an ahpC promoter mutation mediate Mycobacterium tuberculosis resistance to 2-thiophen carboxylic acid hydrazide, an inhibitor resembling the anti-tubercular drugs Isoniazid and Ethionamide. doi:10.1016/j.tube.2018.08.001 names it Tuberculosis (Edinb) 2018
Characterization of the two component regulatory system PhoPR in Mycobacterium bovis. doi:10.1016/j.vetmic.2018.06.016 Vet Microbiol 2018
Proteomic analysis reveals that sulfamethoxazole induces oxidative stress in M. tuberculosis. doi:10.1016/j.tube.2018.05.010 Tuberculosis (Edinb) 2018
Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting. doi:10.1371/journal.pone.0200755 PLoS One 2018
Genotypicdiversity of drug-resistant Mycobacterium tuberculosis isolates from Hebei, China. Int J Clin Exp Pathol 2018
Significance of Coexisting Mutations on Determination of the Degree of Isoniazid Resistance in Mycobacterium tuberculosis Strains. doi:10.1089/mdr.2017.0330 Microb Drug Resist 2018
Roles of three FurA paralogs in the regulation of genes pertaining to peroxide defense in Mycobacterium smegmatis mc(2) 155. doi:10.1111/mmi.13956 Mol Microbiol 2018
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic. doi:10.1186/s12866-018-1168-x BMC Microbiol 2018
[The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones]. doi:10.7868/S0026898417030041 Mol Biol (Mosk) 2017
Mycobacterial DNA-binding protein 1 is critical for long term survival of Mycobacterium smegmatis and simultaneously coordinates cellular functions. doi:10.1038/s41598-017-06480-w Sci Rep 2017
In Silico Prediction of Antibiotic Resistance in Mycobacterium ulcerans Agy99 through Whole Genome Sequence Analysis. doi:10.4269/ajtmh.16-0478 Am J Trop Med Hyg 2017
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand. doi:10.2147/IDR.S130203 Infect Drug Resist 2017
AhpC of the mycobacterial antioxidant defense system and its interaction with its reducing partner Thioredoxin-C. doi:10.1038/s41598-017-05354-5 names it Sci Rep 2017
Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of Mycobacterium tuberculosis strains. doi:10.1016/j.ijantimicag.2017.02.009 Int J Antimicrob Agents 2017
Lack of mycothiol and ergothioneine induces different protective mechanisms in Mycobacterium smegmatis. doi:10.1016/j.bbrep.2016.08.006 Biochem Biophys Rep 2016
A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia. doi:10.1371/journal.pone.0167093 PLoS One 2016
Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC. doi:10.1371/journal.pone.0166807 names it PLoS One 2016
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. doi:10.1016/j.meegid.2016.09.004 Infect Genet Evol 2016
Multi-Fluorescence Real-Time PCR Assay for Detection of RIF and INH Resistance of M. tuberculosis. doi:10.3389/fmicb.2016.00618 Front Microbiol 2016
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012. doi:10.1186/s12866-016-0699-2 BMC Microbiol 2016
Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape. doi:10.1128/AAC.00222-16 Antimicrob Agents Chemother 2016
Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray. doi:10.1093/jac/dkw015 J Antimicrob Chemother 2016
A molecular platform for the diagnosis of multidrug-resistant and pre-extensively drug-resistant tuberculosis based on single nucleotide polymorphism mutations present in Colombian isolates of Mycobacterium tuberculosis. doi:10.1590/0074-02760150306 Mem Inst Oswaldo Cruz 2016
Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China. doi:10.1038/ja.2015.106 J Antibiot (Tokyo) 2016
Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates. doi:10.1016/j.ijmyco.2015.05.007 Int J Mycobacteriol 2015
E1 of α-ketoglutarate dehydrogenase defends Mycobacterium tuberculosis against glutamate anaplerosis and nitroxidative stress. doi:10.1073/pnas.1510932112 Proc Natl Acad Sci U S A 2015
Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. doi:10.1093/jac/dkv253 J Antimicrob Chemother 2015
Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana. doi:10.5588/ijtld.14.0864 Int J Tuberc Lung Dis 2015
Discrepancies in Drug Susceptibility Test for Tuberculosis Patients Resulted from the Mixed Infection and the Testing System. doi:10.1155/2015/651980 Biomed Res Int 2015
Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. doi:10.1371/journal.pone.0119628 PLoS One 2015
Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan. doi:10.1371/journal.pone.0117771 PLoS One 2015
Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1371/journal.pone.0119013 PLoS One 2015
Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China. doi:10.1016/j.jinf.2014.11.008 J Infect 2015
Molecular characterisation of extensively drug-resistant Mycobacterium tuberculosis isolates in China. doi:10.1016/j.ijantimicag.2014.09.018 Int J Antimicrob Agents 2015
Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries. doi:10.1128/AAC.03614-14 Antimicrob Agents Chemother 2015
Automated liquid culture system misses isoniazid heteroresistance in Mycobacterium tuberculosis isolates with mutations in the promoter region of the inhA gene. doi:10.1007/s10096-014-2262-0 Eur J Clin Microbiol Infect Dis 2015
Characterization of phenotypic and genotypic drug resistance patterns of Mycobacterium tuberculosis isolates from a city in Mexico. doi:10.1016/j.eimc.2014.04.005 Enferm Infecc Microbiol Clin 2015
[Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip]. Mol Biol (Mosk) 2014
Regulation of the ahpC gene encoding alkyl hydroperoxide reductase in Mycobacterium smegmatis. doi:10.1371/journal.pone.0111680 names it PLoS One 2014
Detecting novel genetic variants associated with isoniazid-resistant Mycobacterium tuberculosis. doi:10.1371/journal.pone.0102383 PLoS One 2014
Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon. doi:10.1186/1471-2180-14-113 BMC Microbiol 2014
Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1093/jac/dku161 J Antimicrob Chemother 2014
Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis. doi:10.1128/JCM.03395-13 J Clin Microbiol 2014
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China. doi:10.1128/AAC.01792-13 Antimicrob Agents Chemother 2014
Molecular assessment, drug-resistant profile, and spacer oligonucleotide typing (spoligotyping) of Mycobacterium tuberculosis strains from Tamaulipas, México. doi:10.1002/jcla.21650 J Clin Lab Anal 2014
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from south-central in China. doi:10.1038/ja.2013.133 J Antibiot (Tokyo) 2014
The thioredoxin antioxidant system. doi:10.1016/j.freeradbiomed.2013.07.036 Free Radic Biol Med 2014
Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1128/JCM.00857-13 J Clin Microbiol 2014
[Molecular genetic analysis of the isoniazid-resistant strains of M. tuberculosis circulating over the Saratov region]. Mol Gen Mikrobiol Virusol 2013
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. doi:10.1016/j.diagmicrobio.2013.02.035 Diagn Microbiol Infect Dis 2013
Phenotypic and genotypic characteristics of drug resistance in Mycobacterium tuberculosis isolates from pediatric population of Chennai, India. doi:10.4103/0255-0857.103761 Indian J Med Microbiol 2012
Mycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo. doi:10.1111/j.1365-2958.2012.08165.x Mol Microbiol 2012
Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting. doi:10.1186/1471-2180-12-90 BMC Microbiol 2012
Redox biology of tuberculosis pathogenesis. doi:10.1016/B978-0-12-398264-3.00004-8 Adv Microb Physiol 2012
[DNA mutations associated to rifampicin or isoniazid resistance in M. tuberculosis clinical isolates from Sonora, Mexico]. doi:10.1590/s0036-36342012000200013 Salud Publica Mex 2012
Drug resistance of Mycobacterium tuberculosis strains in southern Brazil. doi:10.1590/s0037-86822012000100018 Rev Soc Bras Med Trop 2012
[Rapid detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis using real-time PCR and melting curve analysis]. Zhonghua Jie He He Hu Xi Za Zhi 2011
OsmC proteins of Mycobacterium tuberculosis and Mycobacterium smegmatis protect against organic hydroperoxide stress. doi:10.1016/j.tube.2011.10.021 Tuberculosis (Edinb) 2011
Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan. doi:10.1128/AAC.05101-11 Antimicrob Agents Chemother 2011
Multiplex real-time PCR melting curve assay to detect drug-resistant mutations of Mycobacterium tuberculosis. doi:10.1128/JCM.02046-10 J Clin Microbiol 2011
Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan. Jpn J Infect Dis 2011
Crystal structure of alkyl hydroperoxidase D like protein PA0269 from Pseudomonas aeruginosa: homology of the AhpD-like structural family. doi:10.1186/1472-6807-11-27 BMC Struct Biol 2011
Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR. doi:10.1099/jmm.0.032292-0 J Med Microbiol 2011
Sequence and structural characterization of tbnat gene in isoniazid-resistant Mycobacterium tuberculosis: identification of new mutations. doi:10.1016/j.mrfmmm.2011.03.017 Mutat Res 2011
Mycobacterium avium subsp. Paratuberculosis and the expression of selected virulence and pathogenesis genes in response to 6°C, 65°c and ph 2.0. doi:10.1590/S1517-838220110002000049 Braz J Microbiol 2011
Highest prevalence of the Mycobacterium tuberculosis Beijing genotype isolates in patients newly diagnosed with tuberculosis in the Novosibirsk oblast, Russian Federation. doi:10.1099/jmm.0.027995-0 J Med Microbiol 2011
[Molecular genetic tools for etiologic diagnostics of disseminated lung tuberculosis]. Zh Mikrobiol Epidemiol Immunobiol 2010
Altered protein expression patterns of Mycobacterium tuberculosis induced by ATB107. doi:10.1007/s12275-010-9315-6 J Microbiol 2010
Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana. doi:10.1016/j.ijmm.2010.04.019 Int J Med Microbiol 2010
Partial proteome of Mycobacterium avium subsp. paratuberculosis under oxidative and nitrosative stress. doi:10.1016/j.vetmic.2010.03.025 Vet Microbiol 2010
Rapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis. doi:10.1128/JCM.02036-09 J Clin Microbiol 2010
Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. doi:10.1128/AAC.00964-09 Antimicrob Agents Chemother 2010
A pyrosequencing method for molecular monitoring of regions in the inhA, ahpC and rpoB genes of Mycobacterium tuberculosis. doi:10.1111/j.1469-0691.2009.02932.x names it Clin Microbiol Infect 2010
Genotypic analysis of genes associated with isoniazid and ethionamide resistance in MDR-TB isolates from Thailand. doi:10.1111/j.1469-0691.2009.02838.x Clin Microbiol Infect 2010
[Molecular genetic and bacteriological methods for the diagnosis of multidrug resistant M. tuberculosis]. Tuberk Biolezni Legkih 2009
Global effects of inactivation of the pyruvate kinase gene in the Mycobacterium tuberculosis complex. doi:10.1128/JB.00619-09 J Bacteriol 2009
Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. doi:10.1093/jac/dkp292 J Antimicrob Chemother 2009
Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates. doi:10.1128/AAC.00433-09 Antimicrob Agents Chemother 2009
Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. doi:10.1128/JCM.02499-08 J Clin Microbiol 2009
[Practical value of the TB-biochip MDR test system in the rapid identification of multidrug-resistant M. tuberculosis strains]. Klin Lab Diagn 2009
Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. doi:10.1186/1471-2180-9-39 names it BMC Microbiol 2009
[Distribution of mutations in the rpoB, katG, inhA, ahpC gene of rifampicin and isoniazid resistant M. tuberculosis strains isolated in Kyrgyz Republic]. names it Mol Gen Mikrobiol Virusol 2008
Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. doi:10.1089/mdr.2008.0842 Microb Drug Resist 2008
The alternative sigma factor SigF of Mycobacterium smegmatis is required for survival of heat shock, acidic pH and oxidative stress. doi:10.1099/mic.0.2008/018044-0 Microbiology (Reading) 2008
Mutation in alkylhydroperoxidase D gene dramatically decreases persistence of Mycobacterium bovis bacillus calmette-guerin in infected macrophage. Indian J Med Sci 2008
Phenotypic and genotypic characterization of drug-resistant Mycobacterium tuberculosis strains. doi:10.1016/j.diagmicrobio.2008.06.013 Diagn Microbiol Infect Dis 2008
[Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system]. Georgian Med News 2008
Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. doi:10.1016/j.ijantimicag.2007.08.013 Int J Antimicrob Agents 2008
Peroxiredoxin systems in mycobacteria. doi:10.1007/978-1-4020-6051-9_9 Subcell Biochem 2007
A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array. doi:10.1111/j.1365-2672.2007.03350.x J Appl Microbiol 2007
[Analysis of mutations of multidrug-resistant M. tuberculosis strains in patients with tuberculosis in the Kyrghyz Republic]. Probl Tuberk Bolezn Legk 2007
Development and evaluation of a multiplex PCR for rapid detection and differentiation of Mycobacterium tuberculosis complex members from non-tuberculous mycobacteria. Jpn J Infect Dis 2007
Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. doi:10.1093/jac/dkm054 J Antimicrob Chemother 2007
Molecular analysis of Mycobacterium tuberculosis causing multidrug-resistant tuberculosis meningitis. Int J Tuberc Lung Dis 2007
Proteome and differential expression analysis of membrane and cytosolic proteins from Mycobacterium avium subsp. paratuberculosis strains K-10 and 187. doi:10.1128/JB.01420-06 J Bacteriol 2007
The thiol-based redox networks of pathogens: unexploited targets in the search for new drugs. doi:10.1002/biof.5520270110 Biofactors 2006
[Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system]. Probl Tuberk Bolezn Legk 2006
Compensatory functions of two alkyl hydroperoxide reductases in the oxidative defense system of Legionella pneumophila. doi:10.1128/JB.00635-06 J Bacteriol 2006
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. doi:10.1128/AAC.00112-06 Antimicrob Agents Chemother 2006
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? doi:10.1053/j.gastro.2006.04.021 Gastroenterology 2006
Structure of the inactive variant C60S of Mycobacterium tuberculosis thiol peroxidase. doi:10.1107/S0907444906008249 Acta Crystallogr D Biol Crystallogr 2006
Molecular and physiological effects of mycobacterial oxyR inactivation. doi:10.1128/JB.188.7.2674-2680.2006 J Bacteriol 2006
Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis. doi:10.1128/IAI.74.1.56-63.2006 Infect Immun 2006
Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. doi:10.1128/JCM.43.11.5477-5482.2005 J Clin Microbiol 2005
[Anti-drug pattern of drug-resistant Mycobacterium tuberculosis and analysis of mutation in drug-target genes]. doi:10.11150/kansenshogakuzasshi1970.79.388 Kansenshogaku Zasshi 2005
Thiol specific oxidative stress response in Mycobacteria. doi:10.1016/j.femsle.2005.06.004 FEMS Microbiol Lett 2005
Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona. doi:10.1089/mdr.2005.11.107 Microb Drug Resist 2005
Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. doi:10.1016/j.mimet.2005.03.002 J Microbiol Methods 2005
Structure and mechanism of the alkyl hydroperoxidase AhpC, a key element of the Mycobacterium tuberculosis defense system against oxidative stress. doi:10.1074/jbc.M503076200 names it J Biol Chem 2005
A member of the cAMP receptor protein family of transcription regulators in Mycobacterium tuberculosis is required for virulence in mice and controls transcription of the rpfA gene coding for a resuscitation promoting factor. doi:10.1111/j.1365-2958.2005.04609.x Mol Microbiol 2005
[Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing]. names it Zhonghua Jie He He Hu Xi Za Zhi 2005
Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. doi:10.1128/AAC.49.4.1455-1464.2005 names it Antimicrob Agents Chemother 2005
Use of fluorescence resonance energy transfer for rapid detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Int J Tuberc Lung Dis 2005
Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy. Int J Tuberc Lung Dis 2005
Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. doi:10.1128/AAC.48.9.3373-3381.2004 Antimicrob Agents Chemother 2004
[New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis]. Probl Tuberk Bolezn Legk 2004
Inhibition of Mycobacterium tuberculosis AhpD, an element of the peroxiredoxin defense against oxidative stress. doi:10.1128/AAC.48.7.2424-2430.2004 Antimicrob Agents Chemother 2004
Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines. doi:10.1016/j.ijantimicag.2003.09.032 Int J Antimicrob Agents 2004
Intermolecular interactions in the AhpC/AhpD antioxidant defense system of Mycobacterium tuberculosis. doi:10.1016/j.abb.2004.04.017 names it Arch Biochem Biophys 2004
Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.mimet.2004.02.006 J Microbiol Methods 2004
Multiple thioredoxin-mediated routes to detoxify hydroperoxides in Mycobacterium tuberculosis. doi:10.1016/j.abb.2003.11.021 Arch Biochem Biophys 2004
Typing of Mycobacterium tuberculosis strains resistant to rifampicin and isoniazid by molecular biological methods. doi:10.1023/b:bebm.0000008981.63290.ef Bull Exp Biol Med 2003
Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. doi:10.1016/s0732-8893(03)00132-9 Diagn Microbiol Infect Dis 2003
Detection of resistance to isoniazid by denaturing gradient-gel electrophoresis DNA sequencing in Mycobacterium tuberculosis clinical isolates. New Microbiol 2003
Mutations in katG, inhA, and ahpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. doi:10.1128/JCM.41.9.4471-4474.2003 names it J Clin Microbiol 2003
The mechanism of Mycobacterium tuberculosis alkylhydroperoxidase AhpD as defined by mutagenesis, crystallography, and kinetics. doi:10.1074/jbc.M303747200 J Biol Chem 2003
[Effects of antisense oligo DNA on the antimicrobial activity of reactive oxygen intermediates and antimycobacterial agents against Mycobacterium avium complex]. Kekkaku 2003
Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. doi:10.1128/AAC.47.4.1241-1250.2003 Antimicrob Agents Chemother 2003
Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the beijing strain family. doi:10.3201/eid0811.020507 Emerg Infect Dis 2002
Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages. doi:10.1099/00221287-148-10-3139 names it Microbiology (Reading) 2002
Site-directed mutagenesis reveals a novel catalytic mechanism of Mycobacterium tuberculosis alkylhydroperoxidase C. doi:10.1042/BJ20020545 Biochem J 2002
Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis 2002
The crystal structure of Mycobacterium tuberculosis alkylhydroperoxidase AhpD, a potential target for antitubercular drug design. doi:10.1074/jbc.M200864200 J Biol Chem 2002
Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. doi:10.1126/science.1067798 Science 2002
Production of selenomethionine-labelled proteins using simplified culture conditions and generally applicable host/vector systems. doi:10.1007/s002530100690 Appl Microbiol Biotechnol 2001
Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. doi:10.1128/IAI.69.10.5967-5973.2001 names it Infect Immun 2001
Role of OxyS of Mycobacterium tuberculosis in oxidative stress: overexpression confers increased sensitivity to organic hydroperoxides. doi:10.1016/s1286-4579(01)01422-8 Microbes Infect 2001
AhpC, AhpD, and a secreted 14-kilodalton antigen from Mycobacterium avium subsp. paratuberculosis distinguish between paratuberculosis and bovine tuberculosis in an enzyme-linked immunosorbent assay. doi:10.1128/CDLI.08.4.797-801.2001 names it Clin Diagn Lab Immunol 2001
Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. doi:10.1128/AAC.45.7.2157-2159.2001 Antimicrob Agents Chemother 2001
Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. doi:10.1046/j.1365-2958.2001.02427.x Mol Microbiol 2001
Molecular basis of rifampin and isoniazid resistance in Mycobacterium bovis strains isolated in Sardinia, Italy. doi:10.1128/AAC.45.6.1645-1648.2001 Antimicrob Agents Chemother 2001
Characterization of the Mycobacterium tuberculosis H37Rv alkyl hydroperoxidase AhpC points to the importance of ionic interactions in oligomerization and activity. doi:10.1042/0264-6021:3540209 names it Biochem J 2001
Elevated antibody responses in patients with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis. doi:10.1046/j.1365-3083.2001.00857.x Scand J Immunol 2001
Peroxynitrite reductase activity of bacterial peroxiredoxins. doi:10.1038/35025109 Nature 2000
Mycobacterium tuberculosis H37Rv comparative gene-expression analysis in synthetic medium and human macrophage. doi:10.1016/s0378-1119(00)00249-3 Gene 2000
Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. doi:10.1054/tuld.1999.0231 Tuber Lung Dis 2000
Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. doi:10.1128/JB.182.14.4059-4067.2000 J Bacteriol 2000
The AhpC and AhpD antioxidant defense system of Mycobacterium tuberculosis. doi:10.1074/jbc.M001001200 names it J Biol Chem 2000
Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosis. doi:10.1128/IAI.68.2.801-808.2000 Infect Immun 2000
Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. doi:10.1054/tuld.1998.0195 Tuber Lung Dis 1999
AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis. doi:10.1002/biof.5520100219 names it Biofactors 1999
Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. doi:10.1073/pnas.96.22.12833 Proc Natl Acad Sci U S A 1999
Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997). doi:10.1128/JCM.37.4.998-1003.1999 J Clin Microbiol 1999
Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. doi:10.1086/314677 J Infect Dis 1999
Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. doi:10.1128/IAI.67.1.74-79.1999 Infect Immun 1999
Mechanisms of isoniazid resistance in Mycobacterium tuberculosis. doi:10.1016/s1368-7646(98)80028-9 Drug Resist Updat 1998
[Study on the mutations of ahpC genes in M. tuberculosis isoniazid-resistant isolates]. names it Zhonghua Jie He He Hu Xi Za Zhi 1998
Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties. doi:10.1099/00221287-144-10-2687 names it Microbiology (Reading) 1998
Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis. doi:10.1007/BF01691135 names it Eur J Clin Microbiol Infect Dis 1998
Oxidative stress response and characterization of the oxyR-ahpC and furA-katG loci in Mycobacterium marinum. doi:10.1128/JB.180.18.4856-4864.1998 names it J Bacteriol 1998
Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. doi:10.1016/s1097-2765(00)80079-9 names it Mol Cell 1998
NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. doi:10.1128/JB.180.9.2459-2467.1998 J Bacteriol 1998
Identification of potential CD8+ T-cell epitopes of the 19 kDa and AhpC proteins from Mycobacterium tuberculosis. No evidence for CD8+ T-cell priming against the identified peptides after DNA-vaccination of mice. doi:10.1016/s0264-410x(97)00253-3 names it Vaccine 1998
The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis--a molecular story. doi:10.1099/00222615-47-3-189 J Med Microbiol 1998
Molecular techniques in the diagnosis of drug-resistant tuberculosis. Ann Acad Med Singap 1997
[Rapid diagnosis of tuberculosis]. Kekkaku 1997
Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1128/AAC.41.9.2057 names it Antimicrob Agents Chemother 1997
Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. doi:10.1128/iai.65.4.1395-1401.1997 names it Infect Immun 1997
Interactions of OxyR with the promoter region of the oxyR and ahpC genes from Mycobacterium leprae and Mycobacterium tuberculosis. doi:10.1128/jb.179.7.2401-2409.1997 names it J Bacteriol 1997
Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. doi:10.1128/AAC.41.3.600 names it Antimicrob Agents Chemother 1997
Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. doi:10.1128/jcm.35.3.719-723.1997 J Clin Microbiol 1997
Production of avirulent Mycobacterium bovis strains by illegitimate recombination with deoxyribonucleic acid fragments containing an interrupted ahpC gene. doi:10.1016/s0962-8479(97)90003-4 names it Tuber Lung Dis 1997
Molecular definition and identification of new proteins of Mycobacterium leprae. doi:10.1128/iai.64.12.5425-5427.1996 Infect Immun 1996
Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid. doi:10.1073/pnas.93.23.13212 Proc Natl Acad Sci U S A 1996
The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid. doi:10.1038/nbt1196-1557 Nat Biotechnol 1996
Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. doi:10.1126/science.272.5268.1641 names it Science 1996
Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis. doi:10.1128/jb.178.12.3641-3649.1996 names it J Bacteriol 1996
ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. doi:10.1046/j.1365-2958.1996.449980.x names it Mol Microbiol 1996
Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages. doi:10.1111/j.1365-2958.1995.mmi_17050901.x Mol Microbiol 1995
Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. doi:10.1111/j.1365-2958.1995.mmi_17050889.x Mol Microbiol 1995
Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. doi:10.1073/pnas.92.14.6625 Proc Natl Acad Sci U S A 1995

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Conditional expression context (iModulons)

Member of 1 independently-modulated gene set(s): Fumarate Reductase.

iModulon membership (independently-modulated gene sets from a 647-sample RNA-seq compendium): the conditional co-expression context. Co-expression is a regulatory context, NOT a molecular function. Source: iModulonDB / modulome_mtb (Yoo 2022).

CRISPRi vulnerability

Vulnerability index 1.28 (95% CI -0.35 to 3.90). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.286 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=12 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in oxidative stress response. LPDC|Rv0462, DLAT|Rv2215, AHPD|Rv2429, and AHPC|Rv2428 constitute an NADH-dependent peroxidase and peroxynitrite reductase that provides protection against oxidative stress.
Mycobrowser EC 1.11.1.15 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb2454 · 100.0% identity
M. leprae ML2042 · 86.7% identity
M. marinum MMAR_2755 · 91.8% identity
M. smegmatis MSMEG_4891 · 82.2% identity
M. orygis RJtmp_002511 · 100.0% identity
M. abscessus MAB_4408c · 83.4% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WQB7 SwissProt · reviewed · Evidence at protein level
UniProt nameAlkyl hydroperoxide reductase C
EC (curated) EC 1.11.1.28
Curated functionThiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides. Together with AhpD, DlaT and Lpd, constitutes an NADH-dependent peroxidase active against hydrogen and alkyl peroxides as well as serving as a peroxynitrite reductase, thus protecting the bacterium against reactive nitrogen intermediates and oxidative stress generated by the host immune system. Does not however seem to play a role in detoxification of isoniazid.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category O Post-translational modification, protein turnover, chaperones
Preferred nameahpC
eggNOG descriptionAlkyl hydroperoxide reductase
Orthologous groupCOG0450
EC number EC 1.11.1.15
KEGG orthology K03386
KEGG pathways map04214
Gene Ontology (77) GO:0003674, GO:0003824, GO:0004601, GO:0005575, GO:0005618, GO:0005622, GO:0005623, GO:0005737, GO:0005829, GO:0005886, GO:0006950, GO:0008150 +65 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.401 · quasi-invariant (7 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 3 synonymous, 4 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 51/53 (96%) · mean identity 87.2% · 3/4 closest MTBAP relatives
conserved across the genus (present in 51/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 11/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 54.8%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callNE · non-essential
What the call meansnon-essential
TA sites (Himar1) 10 in the ORF — 0 in the essential state, 0 growth-defect, 10 non-essential, 0 growth-advantage. Saturation 1.000, mean read count 40.2. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 10 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB)

Conditionlog2FCqEffect
altered fitness under Isoniazid (drug exposure) -4.740.0 required
altered fitness under Isoniazid (drug exposure) -3.900.013 required
differential fitness in a comparison whose nature could not be established (upstream metadata defect, see note) (undetermined) +2.520.0063 disruption advantageous

Conditional fitness of transposon-disruption mutants across 3 significant condition(s) (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Provenance note on a condition above. MtbTnDB labels this condition in vivo (Collaborative Cross mouse panel) and attributes it to Smith et al. 2022, eLife 74419. Both are wrong and for the same reason: its left arm, `mbio_H37Rv`, is the saturated H37Rv reference of DeJesus et al. 2017 (mBio 8(1):e02133-16, fourteen independent Tn libraries grown in standard medium), not a mouse strain, and the upstream generator read the token before `_vs_` as a mouse-strain name. The same sample is the in vitro control of six knockout screens in the same file. Measured here on rank correlation over 3971 genes: this condition tracks the other 81 first-order in vivo conditions at rho = +0.03, where those conditions track each other at +0.270 -- it does not behave like an infection measurement. What the comparison actually is could not be established, so it is reported as undetermined rather than renamed, and it is excluded from the in vivo count of this fiche.

Proteomics (mass spectrometry) detected

MS detectiondetected in 16 of 16 independent MS datasets
Integrated abundance666.0 ppm · rank 325/3519 (90.8th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length195 aa
Molecular weight21.6 kDa
Theoretical pI4.5
GRAVY-0.163 (hydrophilic)
Aliphatic index86.6
Aromaticity0.097
Instability index28.5 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
AhpC-TSAPF00578.28 5.7e-3427–146 AhpC/TSA family
RedoxinPF08534.17 6.4e-1332–155 Redoxin

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 2bmx (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 1 solved

PDBMethodResolutionCoverage
2bmx X-ray diffraction 2.4 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (1 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 94.5

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
7bz6-assembly1_B 1.00 0.95 0.87 0.95 99% 92% / 100% 6.8e-36 sig 7bz6-assembly1_B Mycobacterium bovis AhpC
2bmx-assembly1_B 1.00 0.95 0.87 0.95 99% 91% / 100% 6.4e-35 sig 2bmx-assembly1_B Mycobacterium tuberculosis AhpC
2bmx-assembly1_A 1.00 0.96 0.83 0.96 100% 86% / 99% 4.3e-34 sig 2bmx-assembly1_A Mycobacterium tuberculosis AhpC
7bz6-assembly1_A 1.00 0.96 0.83 0.95 99% 87% / 99% 1.2e-33 sig 7bz6-assembly1_A Mycobacterium bovis AhpC
7kiz-assembly1_B 1.00 0.86 0.86 0.86 34% 100% / 99% 4.9e-21 sig 7kiz-assembly1_B reduced human peroxiredoxin 2

Foldseek search of the AlphaFold DB model (mean pLDDT 94.5, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 2

Upstream (5' on genome)proA (- strand, 715 bp gap)
Downstream (3' on genome)ahpD (+ strand, 25 bp gap)
Predicted operon ahpC · ahpD

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 2: ahpC · ahpD — agrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT2503) exponential phase: operon of 2, Rv2428 · Rv2429 (coverage 31.16)
not expressed (stationary phase) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) Rv0047c (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: ahpD (alkyl hydroperoxide reductase AphD), high confidence (score 994, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 128 partners at medium confidence (25 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 128 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv2429 ahpD alkyl hydroperoxide reductase AphD 999 994 ctx neighborhood:844 cooccurence:766 coexpression:837 textmining:902
Rv3913 trxB2 exp (transferred) thioredoxin reductase 955 896 coexpression:437 experimental:808 textmining:588
Rv2874 dipZ exp (transferred) curated integral membrane C-type cytochrome biogenesis protein DipZ 873 834 experimental:468 database:611
Rv1677 dsbF exp (transferred) curated lipoprotein DsbF 882 831 experimental:468 database:611
Rv0816c thiX exp (transferred) curated thioredoxin ThiX 868 831 experimental:468 database:611
Rv3673c exp (transferred) curated membrane-anchored thioredoxin-like protein 841 831 experimental:468 database:611
Rv2878c mpt53 exp (transferred) curated soluble secreted antigen Mpt53 843 830 experimental:468 database:611
Rv0526 exp (transferred) curated thioredoxin 840 830 experimental:468 database:611
Rv2359 zur zinc uptake regulation protein 645 598 coexpression:575
Rv1909c furA ferric uptake regulation protein FurA 870 596 coexpression:573 textmining:692
Rv3841 bfrB bacterioferritin BfrB 664 595 coexpression:562
Rv1875 hypothetical protein 588 589 ctx neighborhood:521
Rv0440 groEL2 molecular chaperone GroEL 661 576
Rv3417c groEL1 chaperonin GroEL 626 576
Rv2521 bcp peroxiredoxin 590 557 ctx cooccurence:467

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: alkyl hydroperoxide reductase subunit AhpC
  • MTBC0 PGAP product: peroxiredoxin AhpC
  • Pfam (hmmscan --cut_ga): AhpC-TSA PF00578.28 (E=6e-34), Redoxin PF08534.17 (E=6e-13)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_216944.1)
  • Domains: Pfam-A via hmmscan --cut_ga — AhpC-TSA (PF00578.28), Redoxin (PF08534.17)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0450
  • Curated reference: UniProt P9WQB7 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 94.5)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 128 functional partner(s); context anchor ahpD
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_002586|Rv2428|ahpC
MPLLTIGDQFPAYQLTALIGGDLSKVDAKQPGDYFTTITSDEHPGKWRVVFFWPKDFTFVCPTEIAAFSKLNDEFEDRDAQILGVSIDSEFAHFQWRAQHNDLKTLPFPMLSDIKRELSQAAGVLNADGVADRVTFIVDPNNEIQFVSATAGSVGRNVDEVLRVLDALQSDELCACNWRKGDPTLDAGELLKASA